马拉维生命科学 MRVI
$7.52 +$0.54 (+7.74%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $7.67 +1.99%
开盘$7.02
昨收$6.98
当日区间$7.01 – $7.62
成交量1.94M
市值$1.12B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$51.44M+8.5% YoY
营业利润-$15.12M+57.8% YoY
净利润-$21.63M+69.0% YoY
摊薄每股收益-$0.08+70.4% YoY
自由现金流$3.62M+127.6% YoY
经营现金流$3.99M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率34.9%
营业利润率-33.7%
净利率-37.1%
净资产收益率-32.9%
资产收益率-10.3%
投入资本回报率-12.2%
流动比率4.05
负债/资产比率41.1%
现金及投资$70.09M
总负债$176.70M
净现金（净负债）-$106.61M
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $51.44M | $65.84M | $185.74M | $49.87M | $41.63M |
| 营业总收入 | $51.44M | $65.84M | $185.74M | $49.87M | $41.63M |
| 营业成本 | $30.79M | $32.14M | $151.75M | $37.02M | $35.98M |
| 毛利润 | $20.65M | $33.70M | $33.99M | $12.84M | $5.66M |
| 营业费用 | $35.77M | $32.98M | $162.52M | $35.37M | $39.24M |
| 销售及管理费用 | $32.07M | $29.09M | $145.12M | $31.58M | $35.40M |
| 研发费用 | $3.70M | $3.89M | $17.40M | $3.79M | $3.84M |
| 营业利润 | -$15.12M | $720,000.00 | -$128.53M | -$22.53M | -$33.59M |
| 非经营性利息净收入（支出） | -$3.65M | -$3.88M | -$15.56M | -$4.17M | -$4.05M |
| 非经营性利息收入 | $1.16M | $1.87M | $11.44M | $2.38M | $2.80M |
| 非经营性利息支出 | $4.81M | $5.75M | $26.99M | $6.56M | $6.84M |
| 其他收入（支出） | -$3.03M | -$3.37M | -$90.89M | -$36.31M | -$7.52M |
| 特殊收益（费用） | -$2.98M | -$2.88M | -$86.74M | -$36.27M | -$7.45M |
| -减：重组及并购费用 | -$33,000.00 | $2.88M | $18.03M | $10.44M | $7.45M |
| -减：资本性资产减值 | $0.00 | $0.00 | $68.71M | $25.83M | $0.00 |
| -减：其他特殊支出 | $3.01M | – | – | – | – |
| 其他非经营性收入（支出） | -$52,000.00 | -$494,000.00 | -$4.15M | -$43,000.00 | -$71,000.00 |
| 税前利润 | -$21.80M | -$6.53M | -$234.97M | -$63.01M | -$45.15M |
| 税费 | -$171,000.00 | -$151,000.00 | -$4.21M | $6,000.00 | -$92,000.00 |
| 净利润 | -$21.63M | -$6.38M | -$230.76M | -$63.02M | -$45.06M |
| 持续经营利润 | -$21.63M | -$6.38M | -$230.76M | -$63.02M | -$45.06M |
| 少数股东权益 | -$9.22M | -$2.64M | -$99.99M | -$27.33M | -$19.50M |
| 归属母公司净利润 | -$12.42M | -$3.73M | -$130.77M | -$35.68M | -$25.56M |
| 归属普通股股东净利润 | -$12.42M | -$3.73M | -$130.77M | -$35.68M | -$25.56M |
| 基本每股收益 | -$0.08 | -$0.02 | -$0.90 | -$0.24 | -$0.18 |
| 摊薄每股收益 | -$0.08 | -$0.02 | -$0.90 | -$0.24 | -$0.18 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $603.75M | $713.22M | $770.58M | $770.58M | $849.19M |
| 流动资产合计 | $155.66M | $251.74M | $296.25M | $296.25M | $325.87M |
| 现金及现金等价物与短期投资 | $70.09M | $165.92M | $216.89M | $216.89M | $243.57M |
| -现金及现金等价物 | $70.09M | $165.92M | $216.89M | $216.89M | $243.57M |
| 应收款 | $31.14M | $33.42M | $25.50M | $25.50M | $22.54M |
| -应收账款 | $31.14M | $33.42M | $25.50M | $25.50M | $22.54M |
| 存货 | $41.23M | $40.46M | $40.50M | $40.50M | $45.33M |
| 其他流动资产 | $13.20M | $11.94M | $13.37M | $13.37M | $14.43M |
| 非流动资产合计 | $448.09M | $461.48M | $474.33M | $474.33M | $523.32M |
| 固定资产净值 | $142.41M | $146.93M | $190.74M | $190.74M | $158.62M |
| -固定资产原值 | $142.41M | $146.93M | $258.82M | $258.82M | $158.62M |
| 商誉及其他无形资产 | $267.80M | $274.32M | $280.97M | $280.97M | $315.31M |
| -商誉 | $129.43M | $129.43M | $129.43M | $129.43M | $129.43M |
| -其他无形资产 | $138.38M | $144.89M | $151.54M | $151.54M | $185.88M |
| 其他非流动资产 | $37.87M | $40.24M | $2.62M | $2.62M | $49.40M |
| 负债合计 | $248.16M | $344.13M | $397.87M | $397.87M | $417.33M |
| 流动负债合计 | $38.42M | $42.62M | $44.92M | $44.92M | $61.57M |
| 应付款 | $7.13M | $8.54M | $3.65M | $3.65M | $8.67M |
| -应付账款 | $7.13M | $8.54M | $2.91M | $2.91M | $8.00M |
| 一年内应计费用 | $30.17M | $28.65M | $11.08M | $11.08M | $21.28M |
| 短期债务及融资租赁负债 | $1.13M | $5.44M | $14.20M | $14.20M | $14.50M |
| -一年内到期债务 | $1.13M | $5.44M | $5.44M | $5.44M | $5.44M |
| 非流动负债合计 | $209.74M | $301.51M | $352.95M | $352.95M | $355.76M |
| 长期债务及融资租赁负债 | $175.57M | $265.44M | $350.51M | $350.51M | $353.44M |
| -长期债务 | $145.98M | $235.57M | $286.33M | $286.33M | $287.38M |
| -长期融资租赁负债 | $29.59M | $29.87M | $64.18M | $64.18M | $66.06M |
| 其他非流动负债 | $34.17M | $36.07M | $197,000.00 | $197,000.00 | $472,000.00 |
| 股东权益合计 | $355.59M | $369.08M | $372.71M | $372.71M | $431.86M |
| 股东权益 | $204.62M | $211.56M | $212.38M | $212.38M | $245.44M |
| 股本 | $2.60M | $2.58M | $2.56M | $2.56M | $2.55M |
| -普通股 | $2.60M | $2.58M | $2.56M | $2.56M | $2.55M |
| 资本公积 | $207.60M | $202.13M | $199.18M | $199.18M | $196.51M |
| 留存收益 | -$6.03M | $6.39M | $10.12M | $10.12M | $45.80M |
| 不影响留存收益的损益 | $459,000.00 | $466,000.00 | $524,000.00 | $524,000.00 | $579,000.00 |
| 少数股东权益 | $150.97M | $157.52M | $160.33M | $160.33M | $186.42M |
| -累计折旧 | – | – | -$68.08M | -$68.08M | – |
| -应付税款合计 | – | – | $742,000.00 | $742,000.00 | $674,000.00 |
| -一年内到期融资租赁负债 | – | – | $8.76M | $8.76M | $9.06M |
| 一年内递延负债 | – | – | $2.99M | $2.99M | $2.62M |
| 其他流动负债 | – | – | $1.89M | $1.89M | $1.95M |
| 长期应付账款及其他应付款 | – | – | $0.00 | $0.00 | $0.00 |
| 一年以上应计费用 | – | – | $0.00 | $0.00 | $0.00 |
| 一年以上递延负债 | – | – | $2.25M | $2.25M | $1.85M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $3.99M | $8.67M | -$57.57M | -$22.77M | -$15.15M |
| 持续经营经营活动现金流净额 | $3.99M | $8.67M | -$57.57M | -$22.77M | -$15.15M |
| 持续经营净利润 | -$21.63M | -$6.38M | -$230.76M | -$63.02M | -$45.06M |
| 折旧、折耗与摊销 | $13.41M | $12.98M | $60.47M | $14.73M | $15.44M |
| 其他非现金项目 | -$340,000.00 | $541,000.00 | $1.87M | -$676,000.00 | $1.65M |
| 营运资金变动 | -$926,000.00 | -$5.83M | -$7.98M | -$19.43M | $4.82M |
| -应收款变动 | $2.29M | -$7.91M | $12.82M | -$2.96M | $5.12M |
| -存货变动 | -$768,000.00 | $33,000.00 | $8.00M | $3.09M | $1.35M |
| -预付资产变动 | -$771,000.00 | $1.43M | $1.63M | $1.18M | $1.07M |
| -应付账款及应计费用变动 | $15,000.00 | $826,000.00 | -$11.97M | -$19.03M | -$657,000.00 |
| -其他流动负债变动 | -$1.69M | -$203,000.00 | -$18.63M | -$1.89M | -$2.06M |
| 投资活动现金流净额 | -$370,000.00 | -$4.44M | -$31.41M | -$2.11M | -$2.93M |
| 持续经营投资活动现金流净额 | -$370,000.00 | -$4.44M | -$31.41M | -$2.11M | -$2.93M |
| 固定资产购置及出售净额 | -$370,000.00 | -$4.44M | -$12.42M | -$2.11M | -$2.93M |
| 业务购买及出售净额 | $0.00 | $0.00 | -$18.99M | $0.00 | $0.00 |
| 筹资活动现金流 | -$98.98M | -$55.23M | -$16.50M | -$1.82M | -$8.25M |
| 持续经营筹资活动现金流净额 | -$98.98M | -$55.23M | -$16.50M | -$1.82M | -$8.25M |
| 债务发行及偿还净额 | -$92.88M | -$51.36M | -$5.44M | -$790,000.00 | -$1.93M |
| 其他筹资费用净额 | -$164,000.00 | -$3.87M | -$11.06M | -$5.63M | -$6.43M |
| 期末现金余额 | $70.58M | $165.92M | $216.89M | $216.89M | $243.57M |
| 现金净变动 | -$95.36M | -$51.00M | -$105.48M | -$26.70M | -$26.33M |
| 期初现金余额 | $165.92M | $216.89M | $322.40M | $243.57M | $269.91M |
| 汇率变动影响 | $17,000.00 | $30,000.00 | -$32,000.00 | $14,000.00 | -$8,000.00 |
| 自由现金流 | $3.62M | $4.23M | -$70.72M | -$24.88M | -$18.81M |
| 递延税款 | – | – | $4.06M | -$20,000.00 | $0.00 |
| -其他流动资产变动 | – | – | $181,000.00 | – | – |
| 股票期权行使所得 | – | – | – | – | $111,000.00 |
暂无评论——快来第一个聊聊 MRVI。
登录后参与讨论。